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Abstract
Introduction: The resistance of microorganisms to antimicrobials has been gradually increasing since 2011 and is now 
recognized by the World Health Organization as a global biological threat. Causes of antimicrobial resistance must be 
actively addressed. Healthcare workers’ awareness of rational antimicrobial prescribing practices is of great impor-
tance. The increasing relevance of this issue is considered within this study, which started in 2014.
Materials and methods: The article represents the results of anonymous prospective surveys within the framework of 
the KANT multi-centered research project aimed at assessing students’ knowledge of rational antimicrobial prescribing 
practices also known as “antimicrobial stewardship”. The survey involved 309 Medical Care majors in their fifth- and 
sixth- years in two Russian regional centers: Belgorod and Voronezh. The answers to four main questions of the survey 
were analyzed in this work. 
Results and discussion: According to the survey, 51.5% of the respondents properly identified a pharmacological 
group of an antimicrobial; 79.3% of the students would change an antibiotic if the desired therapeutic outcome was not 
achieved within two or three days of treatment; 29.8% of the students believed that an antimicrobial substitution was 
required even when a positive therapeutic outcome was achieved; and nobody could correctly identify all the proposed 
pharmacologically irrational combinations of antimicrobials.
Conclusions: The survey showed that senior medical students have insufficient knowledge in antimicrobial steward-
ship.  Appropriate use of antibiotics and antimicrobial prescribing practices need to be considered more thoroughly in 
Pharmacology, Clinical Pharmacology and Medical Care curricula. Likewise, educational activities on antimicrobial 
stewardship and best prescribing practices are of great importance for students as they will help with improving the 
knowledge of future doctors.
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Introduction
Antibiotic resistance is one of the most acute problems in 
the XXI century (CDC 2014, Chellat et al. 2016). Strains 
of antimicrobial-resistant organisms are spreading not 
only across the Russian Federation, but also all over the 
world (Yakovlev et al. 2017, Akova 2016). According 
to the statistical forecasts, the number of deaths caused 
by them may reach 10 million annually by 2050 (Van de 
Sande-Bruinsma 2015). To put that into perspective, the 
world mortality rate caused by all infectious pathologies 
was about 13 million in 2012 (World Health Organization 
Documentation Center 2014), including 700 thousand of 
deaths caused by antimicrobial-resistant microorganisms 
(O’Neill 2014). Mass prescription of antimicrobials has 
led to a significant decrease in the sensitivity of microor-
ganisms to the drugs (Theuretzbacher 2017). Meanwhi-
le, the pipeline for new antimicrobials remains miserable 
(Kozlov 2015, Barber and Swaden-Lewis 2017).
The World Health Organization (WHO) recognized 
the antimicrobial resistance as one of the most significant 
global biological challenges in 2011. Its Global Strategy 
for Containment of Antimicrobial Resistance, developed 
in 2014, considers the following causes of antimicrobial 
resistance (Van de Sande-Bruinsma  2015):
• uncontrolled over-the-counter sale of antimicrobi-
als;
• no common standards for infectious disease treat-
ment;
• no programs for either disease prevention or infec-
tion control;
• use of antimicrobials in food-producing animals;
• low awareness of society and healthcare workers of 
rational antimicrobial chemotherapy.
The above-mentioned problems of antimicrobial re-
sistance must be actively addressed. Rational antimicro-
bial prescribing depends on qualifications and expertise 
of future physicians (Abbo et al. 2013, Bontsevich et al. 
2015). For this purpose, Pharmacology and Clinical Phar-
macology disciplines have been introduced into the cur-
riculum in higher medical educational institutions across 
Russia. Since the largest group of drugs is represented by 
antimicrobial agents, the greatest emphasize in education 
is placed on studying their characteristics, including clas-
sification, components and mechanism of action. During 
the course of Clinical Pharmacology, the following fun-
damentals are considered: practical use of antimicrobial 
agents, optimal doses, dosage interval and possible com-
plications in treatment.
By the fifth and sixth years of study, medical students 
should have appropriate knowledge of antimicrobials 
classification, rational drug combinations, and prevention 
of antimicrobial resistance development. Antibiotic re-
sistance and antimicrobial stewardship issues are not co-
vered sufficiently in the curricula of medical institutions, 
which results in the lack of proper understanding among 
future prescribers as for the significance of this problem 
(CDC 2014). The widespread practice of improper use of 
antimicrobial agents and their combinations is one of the 
most threatening issues in Russia, as well as an overuse 
of parenteral route of administration and improper dosage 
regimens (Strachunskiy et al. 2007)
The increasing relevance of antimicrobial stewardship 
served as the basis for the study within the framework of 
KANT project started in 2014.
The aim of the study: to assess the senior Medical Care 
majors’ knowledge in antimicrobial chemotherapy in me-
dical institutions of Belgorod and Voronezh using the me-
thod of anonymous questioning.
Materials and methods
This article represents the results of a prospective survey 
of senior medical students, within the framework of the 
KANT multi-centered research project (the abbreviation 
of the project “The assessment of students’ (physicians’) 
knowledge in antimicrobials usage”), aimed at asses-
sing the knowledge of rational antibacterial therapy. The 
survey was conducted in 2014–2018 at the Institute of 
Medicine of Belgorod State National Research Univer-
sity (BelSU) (Belgorod) and at Voronezh State Medical 
University named after N.N. Burdenko (Voronezh). Three 
hundred and nine Medical Care majors in their fifth and 
sixth years participated in the survey; 170 of them were 
from Belgorod and 139 – from Voronezh. All the students 
had completed Pharmacology and Clinical Pharmacology 
educational activities.
The method of anonymous questioning was used in 
this study, for which an original questionnaire had been 
developed on the basis of the current clinical guidelines 
(the questions can be found below in the “Results and dis-
cussion” section). 
In the questionnaire, a respondent was to enter a year 
of studies and major, and then was required to answer se-
veral questions. The answers to four main issues of the 
survey were analyzed in this work (given without answer 
choices):
1. Determine the pharmacological group of the pro-
posed antimicrobials; 
2. Indicate pharmacologically irrational combinations 
of the proposed medications; 
3. Specify the time for antimicrobial substitution when 
a positive therapeutic outcome is achieved; 
4. Specify the time for antimicrobial substitution when 
a desired therapeutic outcome is not achieved.
The following score averages for each student were as-
sessed: by question, by city and by the entire questionnai-
re. Since the question about determining an antimicrobial 
group (question No.1) required a mandatory written res-
ponse, when none was provided, 0 points were assigned.
Since the question about pharmacologically irratio-
nal combinations (question No. 2) supposed a variety of 
possible answers, the following assessment system for 
a more detailed analysis was adopted. In case of an in-
complete answer, the respondent was awarded 1 point for 
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each correctly chosen option, which corresponds to 33% 
of correct answers, and 1 point was deducted for each in-
correctly selected drug combination, when a “difficult to 
answer” option was chosen, 0 points were assigned. Thus, 
in case of 100% correct answers, the maximum score was 
“3”, in case of selecting all the possible wrong options, 
the score was “minus 2”.
All the information collected through the questionnai-
res was entered to an electronic database and processed 
using Microsoft Excel applications. Statistical data were 
processed through the analysis of arbitrary contingency 
tables using the Pearson’s chi-square (x2) test.
It is necessary to emphasize that students majored in 
main therapeutic studies including Pharmacology and Cli-
nical Pharmacology. The developed method of knowledge 
assessment is relative, and was specially created for this 
study, and cannot fully reflect the general level of educati-
on quality at university. It part, the primary and intermedi-
ate results of this study were presented in the article “As-
sessment of Senior Students’ Knowledge of Antimicrobial 
Chemotherapy Issues” (Bontsevich et al. 2016).
Results and discussion
In the first question of the questionnaire, the respon-
dents were to classify the proposed antimicrobial agents 
according to pharmacological groups. The list of anti-
biotics was the following: amoxicillin/clavulanic acid, 
ceftriaxone, azithromycin, doxycycline, ciprofloxacin, 
levofloxacin.
The majority of students (53.6%) correctly identified 
all six pharmacological groups of drugs. The rest of the 
students answered correctly the following number of 
questions out of six in such proportions: 15.3% – 5 ans-
wers; 11.8% – 4 answers, 6.8% – 3 answers, 4.7% – 2 
answers, 3.4% – 1 answer, and 4.4% of the respondents 
did not give any correct answers (p(Center1-2) <0.01) (Fig. 1).
The best results were shown when determining the 
antibiotic of the cephalosporins group (91.3%) and pro-
tected aminopenicillins (84.9%). The group of macrolides 
was correctly identified by 77.3% of the students, fluoro-
quinolones of the 2nd and 3rd generation – by 76.9% and 
73.2% of the respondents, respectively. The pharmaco-
logical group of tetracyclines was correctly specified by 
69.6% of the students (Table 1).
A clinician should assess the quality of antimicrobial 
chemotherapy for a patient in dynamics as well as con-
sider positive host responses in the form of improvement 
of the patient’s laboratory markers and his/her general 
well-being. In the second question of the questionnaire, a 
respondent was to specify the terms of an antibiotic sub-
stitution when a positive therapeutic outcome is achieved. 
Obviously, if there are adequate host responses to the an-
timicrobial therapy accompanied by the improvement of a 
patient’s general well-being, no antimicrobial substitution 
is required, of which only 69.3% of the students surveyed 
were aware. The difference between the centers totaled 
25.9% (p <0.001) (Fig. 2).
Treatment efficiency should be initially assessed 
within 48-72 hours after the start of the therapy, focusing 
on the dynamics of systemic inflammatory response syn-
drome and intoxication symptoms. Until that time, it is 
not recommended to change the initial empiric therapy 
(Eurasian Clinical Recommendations 2016). If the desi-
red therapeutic outcome is not achieved or general well-
Figure 1. Distribution of correct answers to the question about pharmacological group of antimicrobials, %
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being is getting worse, antimicrobial substitution is requi-
red and should be made within 2-3 days after prescribing 
the medication. When there is no therapeutic outcome, an 
empiric treatment regimen has to be adjusted within 48-
72 hours after the start of the therapy (Eurasian Clinical 
Recommendations 2016). The number of students who 
answered this question correctly totaled 79.3%, with the 
difference between the study sites being 13.8% (p<0.01) 
(Fig. 3).
To date, antimicrobial resistance growth, cross-re-
sistance and emergence of concurrent infections make 
a challenge for physicians when prescribing a rational 
antimicrobial therapy. At the same time, antimicrobials 
should not overlap in their mechanism of action and anti-
biotic coverage, enhance toxic effects, and should not be 
combined with incompatible medications prescribed to a 
patient. A synergistic action could be achieved by using 
drug combinations. On the other hand, it may cause ad-
verse reactions in patients getting a concomitant pharma-
cotherapy. It should be noted that the bioavailability of 
oral medications may decrease due to the drug interacti-
ons (Strachunskiy et al. 2007).
The next question of the survey was aimed to assess the 
students’ knowledge of rational drugs combinations. They 
were to specify pharmacologically irrational combinati-
ons of antimicrobials. The following drug combinations 
were offered to the respondents: ceftriaxone+amoxicillin; 
ofloxacin+doxycycline; levofloxacin+clarithromycin; am-
picillin+gentamicin; and azithromycin+ampicillin+ami-
kacin.
None of the students gave the correct answer (the first 
three options), which indicates the respondents’ poor 
awareness of rational drug combinations.
Summarizing the results of all correctly and incorrect-
ly chosen options, the largest number of students (124 
people, 40.1%) scored 0% (0 points), with the differen-
ce between the sites being 17%. The majority of the res-
pondents gave an incomplete correct answer: 43 students 
scored 2 points (67% of the correct answers), which was 
13.9% of the total number of the respondents. Eighty-fife 
students (27.5% of the respondents) scored 1 point (33% 
of the correct answers). Forty-eight majors (15.5%) sco-
red ”minus 33%” (-1 point) and 9 students (2.9%) gained 
“minus 66%” (-2 points) (p<0.001) (Fig. 4).
Table 1. Distribution of Correct Answers by the Pharmacological Group of an Antimicrobial Agent
Antimicrobial agent Pharmacological group Correct score averages, %
% Correct scores 
Center 1
% Correct scores 
Center 2
amoxicillin / clavulanic acid protected aminopenicillins 84.9 73.6 97.8
ceftriaxone cephalosporins (3d gen) 91.3 85 98.6
azithromycin macrolides 77.3 66.3 89.9
doxycycline tetracyclines 69.6 60 88.5
ciprofloxacin fluoroquinolones (2d gen) 73.2 62.5 93.5
levofloxacin
fluoroquinolones (3d gen), 
respiratory fluoroquinolones
76.9 53.7 87.8
Figure 2. Distribution of correct answers concerning the necessity and terms of antimicrobial substitution when a positive thera-
peutic outcome is achieved, %
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The best result was recorded when choosing the ir-
rational combination “ceftriaxone+amoxicillin” (38.5% 
of correct answers, the difference between the centers is 
16.3%), the options “ofloxacin+doxycycline” and “levof-
loxacin+clarithromycin” were correctly chosen by 21% 
and 18.1% of the respondents, respectively (Table 2).
Almost a third of the respondents (30.7%, the differen-
ce between the centers is 1.6%) considered the rational 
combination of “azithromycin+ampicillin+amikacin” as 
“irrational”. The rational combination of “ampicillin+-
gentamicin” was chosen as incorrect by 12.9% of the res-
pondents (Table 3).
Figure 3. Distribution of answers to the question about the necessity and terms of antimicrobial substitution when a desired thera-
peutic outcome is not achieved, %
Figure 4. Distribution of students by knowledge scores when answering about rational drug combinations, %
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Conclusions
This survey of the fifth- and sixth-year Medical Care ma-
jors showed a low level of preparedness in antimicrobi-
al stewardship. More than a half of the graduates gave 
wrong (or not completely correct) answers to the funda-
mental questions. The most difficult question was about 
the choice of pharmacologically rational and irrational 
combinations of drugs: none of the students gave a com-
pletely correct answer, 13,9% of the respondents scored 
2/3 of the correct answers.
According to the authors, to date, rational antimicrobi-
al use in not sufficiently covered in the curricula of higher 
medical schools in Russia, which undermines the level of 
future prescribers’ knowledge. One of the possible rea-
sons for the irrational tactics of infectious diseases treat-
ment is the low level of doctors’ preparedness, including 
insufficient knowledge of either the etiological structure 
of infections or the fundamentals of clinical pharmaco-
logy of antibiotics (Strachunskiy et al. 2007).
This study gives an opportunity to identify strengths 
and weaknesses and draw attention to those points that 
cause maximum difficulties. The survey showed that the 
growing problem of antimicrobial resistance should be 
addressed by an increase in the number of practical class 
hours for training future doctors in the principles and 
practices of appropriate use of antibiotics and antimicro-
bial stewardship.
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